Saliva Test Device Market Report 2025

The saliva test device market size has grown strongly in recent years. It will grow from $1.06 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. Growth in the historic period was driven by rising R&D investments, broader adoption in disease diagnostics, increased forensic and research utilization, greater consumer interest in home-based testing, and a heightened need for multiplex testing solutions.

The saliva test device market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. Forecasted growth is attributed to rising interest in non-invasive testing, an increasing burden of chronic illnesses, greater attention toward personalized medical solutions, expanded use of point-of-care diagnostics, and rising relevance of remote and telehealth testing. Prominent trends expected in the future include innovation in biosensor technology, development of microfluidic systems, incorporation with smartphone diagnostics, integration of technology into home-based test kits, and the emergence of AI-powered platforms for saliva analysis.

The rising prevalence of infectious diseases is playing a key role in driving the saliva test device market. These illnesses, caused by bacteria, viruses, fungi, or parasites, can be transmitted from person to person either directly or indirectly. A key reason behind the increase in such diseases is the surge in international travel, which enables faster transmission of pathogens. Saliva test devices provide a user-friendly and non-invasive approach to detecting these infections, making them suitable for home and point-of-care diagnostics. By delivering prompt and reliable results, these devices aid in early detection and effective management of infections. For example, as reported by the UK Health Security Agency in February 2024, the number of tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. This growing disease burden is supporting the expansion of the saliva test device market.

Leading companies in the saliva test device market are prioritizing the development of cutting-edge technologies, particularly by incorporating artificial intelligence in saliva-based testing. This integration aims to enhance diagnostic precision, provide immediate data interpretation, and improve user experience. AI-driven analysis helps detect patterns in test data and enables rapid, more reliable results. As an example, in July 2024, US-based Ovulio Corp. introduced a new AI-enabled fertility tracker that analyzes saliva samples. This innovation provides a non-invasive and efficient tool for monitoring ovulation and hormone levels, giving users real-time, accurate reproductive health insights for planning and wellness.

In December 2023, India-based Molbio Diagnostics Pvt. Ltd. entered into a partnership with Finland-based Testi Technologies Oy to globally market and distribute advanced saliva-based self-testing kits. The purpose of this collaboration is to expand access to easy-to-use, fast diagnostic tools and reinforce the global infrastructure for point-of-care testing. Testi Technologies Oy focuses on creating innovative saliva testing devices, making this partnership a significant move toward the broader availability of non-invasive diagnostic solutions.

Major players in the saliva test device market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Incorporated, PerkinElmer Inc., AncestryDNA, Neogen Corporation, OraSure Technologies Inc., Guangzhou Wondfo Biotech Co. Ltd., 23andMe Inc., Porex Corporation, Everlywell Inc., DNA Genotek Inc., Premier Biotech Inc., Oasis Diagnostics Corporation, Salimetrics LLC, Securetec Detektions-Systeme AG, AccuBioTech Co. Ltd., Abionic SA, MyLab Box Inc., Oranoxis Inc., and Salignostics Ltd.

North America was the largest region in the saliva test device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in saliva test device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the saliva test device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The saliva test device market consists of revenues earned by entities by providing services such as saliva sample collection, diagnostic testing, result interpretation, remote health monitoring, and at-home testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The saliva test device market also includes sales of oral swab test kits, rapid saliva test devices, and saliva-based diagnostic tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The saliva test device market research report is one of a series of new reports that provides saliva test device market statistics, including the saliva test device industry's global market size, regional shares, competitors with the saliva test device market share, detailed saliva test device market segments, market trends and opportunities, and any further data you may need to thrive in the saliva test device market. This saliva test device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A saliva test device is a tool used to identify specific biomarkers or substances present in an individual's saliva. It is known for being non-invasive, simple to use, and often provides quick results. The primary function of this device is to detect health conditions such as infections, drug usage, hormonal imbalances, and various diseases. These devices are commonly utilized in medical diagnostics, forensic investigations, and at-home testing environments.

Saliva test devices are available in several types, including 5-panel, 6-panel, 10-panel, 12-panel kits, and others. A 5-panel saliva test kit is specifically designed to identify five particular substances or biomarkers and is frequently employed in routine drug or health screening. The devices use different sample types such as saliva, blood, and urine, and employ various analytical methods like immunoassay, polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and microarray. These technologies are implemented across diverse applications including workplace testing, criminal justice, and disease diagnosis, and are used by end users such as hospitals, clinics, diagnostic labs, and home care providers.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.